Navigation Links
Promising Data on Cognitive Effects of Safinamide in Early,Parkinson's Disease

cal movement (akinesia). The primary symptoms are the results of decreased stimulation of the motor cortex by the basal ganglia, normally caused by the insufficient formation and action of dopamine, which is produced in the dopaminergic neurons of the brain. Secondary symptoms may include high level cognitive dysfunction and subtle language problems. Parkinson’s disease is both chronic and progressive.

Forward-looking statements
Some of the statements in this press release are forward looking. Such statements are inherently subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of Merck Serono S.A. and affiliates to be materially different from those expected or anticipated in the forward-looking statements. Forward-looking statements are based on Merck Serono’s current expectations and assumptions, which may be affected by a number of factors, including those discussed in this press release and more fully described in Serono’s Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission on February 28, 2006. These factors include any failure or delay in Merck Serono’s ability to develop new products, any failure to receive anticipated regulatory approvals, any problems in commercializing current products as a result of competition or other factors, our ability to obtain reimbursement coverage for our products, the outcome of any government investigations and litigation. Merck Serono is providing this information as of the date of this press release, and has no responsibility to update the forward-looking statements contained in this press release to reflect events or circumstances occurring after the date of this press release.

About Newron Pharmaceuticals
Newron Pharmaceuticals S.p.A. (www.newron.com) is a biopharmaceutical company focused on novel therapies
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
2. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
3. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
4. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
5. Antisense Pharma: Promising Phase IIb Results of Targeted Therapy with AP 12009 in Recurrent Anaplastic Astrocytoma
6. Promising Results with Epratuzumab and Chemotherapy in Children with Acute Lymphoblastic Leukemia
7. Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90 Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory Breast and Ovarian Cancers at ASCO
8. Investigational Cancer Drug Pertuzumab Shows Promising Results in Advanced Breast Cancer When Combined with Herceptin
9. Kosan Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Epothilone KOS-1584 at ASCO
10. Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing Promising Antitumor Activity in Multiple Myeloma at ASCO
11. Pharmacyclics Announces Promising Results From Phase 2 Clinical Trial of Xcytrin in Recurrent, Metastatic Non-Small Cell Lung Cancer
Post Your Comments:
(Date:8/3/2015)... , Aug. 3, 2015  Dr. ... Orthopaedic & Spine Center today, providing ... manage their chronic pain through psychological counseling and ... is a Fellowship-trained, certified medical psychologist with an ... His vast experience ranges from assessment and treatment ...
(Date:8/3/2015)... -- BioElectronics Corporation (OTC Pink: BIEL), maker of consumer medical ... J. Whelan , President will be interviewed by ... 9am EDT on Wednesday, August 5 th .  To ... http://tunein.com/radio/Money-Matters-Boston-1120-s27548/ Mr. Whelan is ... flagship product, ActiPatch Therapy, is achieving in the UK.  ...
(Date:8/3/2015)... SAN FRANCISCO, Calif. , Aug. 3, 2015 ... for the treatment of cancer, today announced the ... Debanjan Ray , who previously ... alliance management, has been promoted to senior vice ... joining CytomX, Mr. Ray held positions as the ...
Breaking Medicine Technology:Orthopaedic & Spine Center Introduces New Pain Psychologist 2UpTick News Wire Radio Show Will Interview BioElectronics' CEO Andrew Whelan 2CytomX Announces Management Team Promotions 2CytomX Announces Management Team Promotions 3
... 2007 /PRNewswire-FirstCall/ -- Advanced Life,Sciences Holdings, Inc. ... the first of two pivotal Phase 3 ... effectiveness of cethromycin, a,novel once-a-day antibiotic, for ... the study, cethromycin achieved,non-inferiority in its primary ...
... Pharmexa-Epimmune, the U.S.-based subsidiary of,Pharmexa A/S, presents ... at the Influenza Conference entitled, "Options for,the ... Ontario, Canada. The,data show that a "universal" ... protect transgenic mice against,lethal experimental influenza virus ...
Cached Medicine Technology:Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia,Clinical Trial 2Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia,Clinical Trial 3Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia,Clinical Trial 4Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia,Clinical Trial 5Pharmexa A/S (DK) - Pharmexa presents data from influenza program 2
(Date:8/3/2015)... ... August 04, 2015 , ... Approved ... extensive line up of live courses for the month of August. , Physical ... individually or by purchasing a Physical Therapy Flex package. Flex packages allow ...
(Date:8/3/2015)... ... ... the most affordable web design and SEO services for start up companies. Every start ... Every company that is starting out needs to be online in this technology advanced ... start up need to be online, they need to physically be present and visible online. ...
(Date:8/3/2015)... ... August 03, 2015 , ... sweetFrog Enterprises, LLC. is ... is the 20th sweetFrog store operating in the Lone Star State. The premium frozen ... companies in 2014. , The store, located at 2916 US-75, Sherman, TX 38652, will ...
(Date:8/3/2015)... ... August 03, 2015 , ... Code , an industry leader of ... a Bluetooth Code Reader accessory that enables a wireless connection between the CR5000 ... enable a variety of barcode reading applications with iPads, Galaxy Tabs, and many other ...
(Date:8/3/2015)... ... ... an opinion piece published July 28 by the Washington Post, the conventional wisdom ... may not be accurate. While this system may work for some people, the author notes ... both on the individual and at what point that person is in their weight loss ...
Breaking Medicine News(10 mins):Health News:Elite Online CE Provider Announces Schedule of Live Courses For Florida Physical Therapy Continuing Education 2Health News:Elite Online CE Provider Announces Schedule of Live Courses For Florida Physical Therapy Continuing Education 3Health News:Web SEO Master, a division of SH Web Design & SH Web Commerce, Inc. begins offering Web Design and SEO Services for Start Up Companies located in Indianapolis, Indiana 2Health News:Web SEO Master, a division of SH Web Design & SH Web Commerce, Inc. begins offering Web Design and SEO Services for Start Up Companies located in Indianapolis, Indiana 3Health News:sweetFrog Reopens Texas Store Today 2Health News:Code Launches the T500, an Innovative Code Reader Accessory 2Health News:Code Launches the T500, an Innovative Code Reader Accessory 3Health News:Article Dispelling Weight Loss Myth Correctly Emphasizes the Complicated and Difficult Nature of Weight Loss, Says Dr. Michael Feiz 2
... psychologists to be published online Oct. 28 by the ... colorliterally and figurativelyto the age-old question of what attracts ... Elliot, professor of psychology, and Daniela Niesta, post-doctoral researcher, ... amorous toward women. And men are unaware of the ...
... HealthSouth,Corporation (NYSE: HLS ) today, in response to ... previously announced full year 2008,guidance and the continued strength ... In addition, HealthSouth noted the following:, -- ... year to date,through October 27, 2008, and debt reduction ...
... /PRNewswire-FirstCall/ - In accordance with the,Rules of the ... RPBIF) (the "Company") today announced that certain insiders,(the ... financing announced,on October 14, 2008 (the "Financing")., ... of an,aggregate of (up to) 36.67 million units ...
... 27 Parrish Medical Center, a,210-bed community hospital ... Clinical Xpert Navigator which are both part of ... Healthcare business of,Thomson Reuters., These tools enable ... give clinicians access to comprehensive patient,information at any ...
... Plavix action, study says , , MONDAY, Oct. 27 (HealthDay ... prescribed for coronary conditions, might reduce the effect of ... Calcium channel blockers appear to inactivate an enzyme essential ... Austrian physicians published online Oct. 28 in the ...
... Year-over-year service revenue growth of 26.4% ... - GAAP diluted earnings per share of $0.23, BOSTON, ... announced its financial results for the,first quarter ended September 30, ... PAREXEL,s consolidated,service revenue increased 26.4% to $263.0 million compared with ...
Cached Medicine News:Health News:Psychological study reveals that red enhances men's attraction to women 2Health News:Psychological study reveals that red enhances men's attraction to women 3Health News:HealthSouth Reaffirms Business Fundamentals and Full Year 2008 Guidance 2Health News:HealthSouth Reaffirms Business Fundamentals and Full Year 2008 Guidance 3Health News:Response Biomedical Announces Insider Participation in Current Financing 2Health News:Response Biomedical Announces Insider Participation in Current Financing 3Health News:Response Biomedical Announces Insider Participation in Current Financing 4Health News:Response Biomedical Announces Insider Participation in Current Financing 5Health News:Response Biomedical Announces Insider Participation in Current Financing 6Health News:Parrish Medical Center Deploys Clinical Xpert(TM) Solutions from Thomson Reuters 2Health News:Parrish Medical Center Deploys Clinical Xpert(TM) Solutions from Thomson Reuters 3Health News:Common Heart Drugs May Hamper Blood Thinner 2Health News:Common Heart Drugs May Hamper Blood Thinner 3Health News:PAREXEL Reports First Quarter Fiscal Year 2009 Financial Results 2Health News:PAREXEL Reports First Quarter Fiscal Year 2009 Financial Results 3Health News:PAREXEL Reports First Quarter Fiscal Year 2009 Financial Results 4Health News:PAREXEL Reports First Quarter Fiscal Year 2009 Financial Results 5Health News:PAREXEL Reports First Quarter Fiscal Year 2009 Financial Results 6Health News:PAREXEL Reports First Quarter Fiscal Year 2009 Financial Results 7Health News:PAREXEL Reports First Quarter Fiscal Year 2009 Financial Results 8Health News:PAREXEL Reports First Quarter Fiscal Year 2009 Financial Results 9
... Alfa acetabular cup system has been designed ... a tri-spiked and cluster hole configurations. The ... minimize micromotion on three primary modes: Tilt, ... design features result in initial and long-term ...
The Biopro All Poly cup is a uniquely designed UHMWPE acetabular cup....
The Plasmacup SC satisfies two important requirements: high primary stability and a low friction bearing surface....
The cementless biomEx cup can be used with both cemented and cementless femoral stems....
Medicine Products: